IT-901 CAS 1584121-99-2

Product Description:

Product Name: IT-901 CAS NO: 1584121-99-2

Synonyms:

5-[(2,4-Dimeth-oxy-1-naphthalenyl)methylene]dihydro-2-thioxo-4,6(1H,5H)-pyrimidinedione;

4,6(1H,5H)-Pyrimidinedione, 5-[(2,4-dimeth-oxy-1-naphthalenyl)methylene]dihydro-2-thioxo-;

Chemical & Physical Properties:

Appearance: Off-white to white solid

Assay :≥99.0%

Storage: Dry, dark and at 0 – 4℃ for short term (days to weeks) or -20℃ for long term (months to years).

Solubility: Soluble in DMSO

IT-901 is an orally active and potent NF-κB subunit c-Rel inhibitor with an IC50 of 0.1 µM, 3 μM for NF-κB DNA binding and c-Rel DNA binding, respectively. IT-901, a bioactive naphthalenethiobarbiturate derivative, has the potential for human lymphoid tumors and ameliorate graft-versus-host disease (GVHD). IT 901, a bioactive naphthalenethiobarbiturate derivative, potently inhibits the NF-κB subunit c-Rel with IC50 value of 3 μM. It shows its anticancer properties in Hematologic Malignancies by inhibiting the oxidative stress response in lymphoma cells. It suppressed graft-versus-host disease while preserving graft-versus-lymphoma activity during allogeneic transplantation. It did not elicit increased levels of reactive oxygen species in normal leukocytes, illustrating its cancer selective properties. It is used for the treatment of human B-cell lymphoma and reveals antitumor properties in vitro and in vivo. It is also a novel therapeutic agent to ameliorate graft-versus-host disease.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.